摘要
早产是5岁以下儿童的主要死亡原因之一。宫缩抑制剂可延长妊娠时间,是治疗早产的重要措施之一。然而在临床使用中,药物的使用指征、疗效监测、治疗时间和安全性监测仍存在许多问题。本文基于早产相关指南,结合临床实践,对早产患者宫缩抑制剂使用中的一些问题进行评述,为早产管理提供帮助。
Premature birth is one of the leading causes of death in children under 5 years of age.Tocolytic inhibitors can prolong pregnancy time and are one of the important treatment measures for preterm birth.However,there are still many problems in the indications,efficacy monitoring,course of treatment,and safety monitoring of drugs in clinical use.Based on the relevant guidelines for preterm birth and in combina‑tion with the clinical practice,this paper reviews some problems in the use of tocolytics in preterm labor,so as to provide help for the management of preterm birth.
作者
张力
刘丹
张伶俐
Zhang Li;Liu Dan;Zhang Lingli(Department of Obstetrics and Gynecology,Key Laboratory of Birth Defects and Related Diseases of Women and Children,West China Second University Hospital,Sichuan University,Chengdu 610041,China;Depart‑ment of Pharmacy,Evidence‑Based,Pharmacy Center,Key Laboratory of Birth Defects and Related Diseases of Women and Children,West China Second University Hospital,Sichuan University,Chengdu 610041,China)
出处
《药物不良反应杂志》
CSCD
2023年第7期385-388,共4页
Adverse Drug Reactions Journal
关键词
早产
宫缩抑制剂
保胎
安全性
Preterm birth
Tocolytic agents
Tocolysis
Safety
